• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH embraces 12-year scientific vision for BRAIN Initiative

NIH embraces 12-year scientific vision for BRAIN Initiative

June 11, 2014
CenterWatch Staff

A federal report calls for $4.5 billion in funding for brain research over the next 12 years. The long-term scientific vision of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was presented to NIH Director Francis S. Collins, M.D., Ph.D., by his Advisory Committee to the Director (ACD). Collins accepted the recommendations, calling the report bold and game changing.

“How the brain works and gives rise to our mental and intellectual lives will be the most exciting and challenging area of science in the 21 century,” said Collins. “As a result of this concerted effort, new technologies will be invented, new industries spawned and new treatments and even cures discovered for devastating disorders and diseases of the brain and nervous system.”

The report drafted by the ACD BRAIN Working Group maps out a sustained commitment of $4.5 billion in new federal funding over 10 years beginning in fiscal year 2016 to achieve seven primary goals. NIH already announced an investment of $40 million in fiscal year 2014 and President Obama has made a request for $100 million for NIH’s component of the initiative in his fiscal year 2015 budget.

The NIH efforts on the BRAIN Initiative will seek to map the circuits of the brain, measure the fluctuating patterns of electrical and chemical activity flowing within those circuits and understand how their interplay creates our unique cognitive and behavioral capabilities. The following scientific goals were identified as high priorities for achieving this vision:

  • Identify and provide experimental access to the different brain cell types to determine their roles in health and disease
  • Generate circuit diagrams that vary in resolution from synapses to the whole brain
  • Produce a dynamic picture of the functioning brain by developing and applying improved methods for large-scale monitoring of neural activity
  • Link brain activity to behavior with precise interventional tools that change neural circuit dynamics
  • Produce conceptual foundations for understanding the biological basis of mental processes through development of new theoretical and data analysis tools
  • Develop innovative technologies to understand the human brain and treat its disorders
  • Create and support integrated brain research networks
  • Integrate new technological and conceptual approaches produced in the other goals to discover how dynamic patterns of neural activity are transformed into cognition, emotion, perception and action in health and disease.

These scientific goals will be maximized through seven core principles:

  • Pursue human studies and non-human models in parallel
  • Cross boundaries in interdisciplinary collaborations
  • Integrate spatial and temporal scales
  • Establish platforms for preserving and sharing data
  • Validate and disseminate technology
  • Consider ethical implications of neuroscience research
  • Create mechanisms to ensure accountability to the NIH, the taxpayer and the community of basic, translational and clinical neuroscientists

The Working Group outlined an investment ramping up to $400 million a year for fiscal years 2016-2020 to focus on technology development and validation. They called for $500 million a year for years 2020-2025 to increasingly focus on the application of those technologies in an integrated fashion to make fundamental new discoveries about the brain. The working group emphasized that its cost estimates assume that the budget for the BRAIN Initiative will supplement—not supplant—NIH’s existing investment in the broader spectrum of basic, translational and clinical neuroscience research.

“While these estimates are provisional and subject to congressional appropriations, they represent a realistic estimate of what will be required for this moon shot initiative,” said Collins. “As the Human Genome Project did with precision medicine, the BRAIN Initiative promises to transform the way we prevent and treat devastating brain diseases and disorders, while also spurring economic development.”

In December 2013, NIH announced six funding opportunities in response to high priority areas identified by the BRAIN Working Group. Awards are expected to be announced in September.

The BRAIN Initiative is jointly led by NIH, Defense Advanced Research Projects Agency of the U.S. Department of Defense, National Science Foundation and the FDA. Private organizations also are committed to ensuring success through investment in the initiative.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing